Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 88LOXO ONCOL ELI LILLY

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
PharmaVenue
Not Confirmed
arrow
PharmaVenue
Not Confirmed

SELPERCATINIB

US Patent Number : 10172851

Drug Substance Claim :

Drug Product Claim :

Application Number : 213246

Patent Use Code : U-3450

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2037-10-10

blank

02

arrow
PharmaVenue
Not Confirmed
arrow
PharmaVenue
Not Confirmed

SELPERCATINIB

US Patent Number : 12138250

Drug Substance Claim :

Drug Product Claim :

Application Number : 218160

Patent Use Code : U-3949

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-10-10

blank

03

arrow
PharmaVenue
Not Confirmed
arrow
PharmaVenue
Not Confirmed

SELPERCATINIB

US Patent Number : 12138250

Drug Substance Claim :

Drug Product Claim :

Application Number : 218160

Patent Use Code : U-3951

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-10-10

blank

04

arrow
PharmaVenue
Not Confirmed
arrow
PharmaVenue
Not Confirmed

SELPERCATINIB

US Patent Number : 12138250

Drug Substance Claim :

Drug Product Claim :

Application Number : 218160

Patent Use Code : U-3951

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-10-10

blank

05

arrow
PharmaVenue
Not Confirmed
arrow
PharmaVenue
Not Confirmed

SELPERCATINIB

US Patent Number : 12138250

Drug Substance Claim :

Drug Product Claim :

Application Number : 218160

Patent Use Code : U-3951

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-10-10

blank

06

arrow
PharmaVenue
Not Confirmed
arrow
PharmaVenue
Not Confirmed

SELPERCATINIB

US Patent Number : 12138250

Drug Substance Claim :

Drug Product Claim :

Application Number : 218160

Patent Use Code : U-3951

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-10-10

blank

07

arrow
PharmaVenue
Not Confirmed
arrow
PharmaVenue
Not Confirmed

SELPERCATINIB

US Patent Number : 12138250

Drug Substance Claim :

Drug Product Claim :

Application Number : 218160

Patent Use Code : U-3950

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-10-10

blank

08

arrow
PharmaVenue
Not Confirmed
arrow
PharmaVenue
Not Confirmed

SELPERCATINIB

US Patent Number : 12138250

Drug Substance Claim :

Drug Product Claim :

Application Number : 218160

Patent Use Code : U-3950

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-10-10

blank

09

arrow
PharmaVenue
Not Confirmed
arrow
PharmaVenue
Not Confirmed

SELPERCATINIB

US Patent Number : 12138250

Drug Substance Claim :

Drug Product Claim :

Application Number : 218160

Patent Use Code : U-3950

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-10-10

blank

10

arrow
PharmaVenue
Not Confirmed
arrow
PharmaVenue
Not Confirmed

SELPERCATINIB

US Patent Number : 12138250

Drug Substance Claim :

Drug Product Claim :

Application Number : 218160

Patent Use Code : U-3950

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2038-10-10

blank